Assessment of exhaled breath condensate pH in asthma and COPD patients with exacerbation Source: Annual Congress 2010 - COPD: treatment and monitoring Year: 2010
The biomarkers of atopy in exhaled breath condensate in patients with bronchial asthma Source: Annual Congress 2010 - Biomarkers and Diagnosis of asthma and allergic respiratory diseases Year: 2010
Prediction of asthma exacerbations in children by FeNO and non-invasive inflammatory markers in exhaled breath condensate Source: Annual Congress 2008 - Assessment of inflammation, hyperresponsiveness and response to exercise in asthmatic children Year: 2008
Exhaled breath condensate for evaluation of inflammation in COPD patients Source: Eur Respir J 2006; 28: Suppl. 50, 35s Year: 2006
Conductivity in exhaled breath condensate of patients with asthma, COPD or cystic fibrosis Source: Eur Respir J 2005; 26: Suppl. 49, 227s Year: 2005
Prediction of CF exacerbations by FeNO and non-invasive inflammatory markers in exhaled breath condensate Source: Annual Congress 2008 - Cystic fibrosis: novel aspects of airway function and inflammation Year: 2008
Relationship between sputum analysis, methacholine challenge testing and exhaled breath condensate pH in patients with mild-to-moderate well-controlled asthma Source: Annual Congress 2010 - Induced sputum in relation: a fresh look on phenotyping and monitoring Year: 2010
Changes in exhaled breath condensate in asthma and COPD: A full analysis of mass-spectra Source: Annual Congress 2010 - Exhaled biomarkers: smells like disease Year: 2010
8-isoprostane in breath condensate in patients with exacerbation of COPD Source: Eur Respir J 2001; 18: Suppl. 33, 248s Year: 2001
The role of galactomannan in exhaled breath condensate in detecting pulmonary aspergillosis in patients with exacerbated COPD Source: Annual Congress 2012 - Prognostic indices in respiratory infections Year: 2012
Early detection of patients with asthma or chronic bronchitis by investigation on exhaled air condensate Source: Eur Respir J 2002; 20: Suppl. 38, 275s Year: 2002
Relationship of inflamamatory markers in blood and exhaled breath condensate in COPD patients Source: Eur Respir J 2006; 28: Suppl. 50, 283s Year: 2006
Detection and variability of cytokine-levels in exhaled breath condensate (EBC) of patients with stable COPD Source: Eur Respir J 2003; 22: Suppl. 45, 438s Year: 2003
Cystenil-leukotrienes as markers of airway inflammation in exhaled breath condensate of asthmatic children Source: Eur Respir J 2002; 20: Suppl. 38, 412s Year: 2002
Cytokines in exhaled breath condensate of patients with asthma Source: Annual Congress 2008 - Inflammatory biomarkers Year: 2008
Nitrite levels in breath condensate of children with bronchial asthma Source: Eur Respir J 2001; 18: Suppl. 33, 269s Year: 2001
Content of nitric oxide in the exhaled breath condensate, induced sputum and BAL in asthma and COPD patients Source: Eur Respir J 2006; 28: Suppl. 50, 369s Year: 2006
Decreased levels of bis-S-bimane in exhaled breath condensate of COPD Source: International Congress 2015 – Exhaled biomarkers in children and adults with airways disease Year: 2015
Eosinophil and neutrophilic chemotactic activity in the exhaled breath condensate of stable patients with asthma and COPD Source: Eur Respir J 2005; 26: Suppl. 49, 734s Year: 2005
Exhaled breath condensate biomarkers in COPD Source: Eur Respir J 2008; 32: 472-486 Year: 2008